Avid Bioservices Inc
NASDAQ:CDMO
Balance Sheet
Balance Sheet Decomposition
Avid Bioservices Inc
Current Assets | 103.6m |
Cash & Short-Term Investments | 30.7m |
Receivables | 30.7m |
Other Current Assets | 42.1m |
Non-Current Assets | 351.6m |
PP&E | 229.1m |
Other Non-Current Assets | 122.6m |
Current Liabilities | 222.9m |
Accounts Payable | 19.5m |
Accrued Liabilities | 5.4m |
Short-Term Debt | 141.4m |
Other Current Liabilities | 56.5m |
Non-Current Liabilities | 52.2m |
Long-Term Debt | 7.5m |
Other Non-Current Liabilities | 44.7m |
Balance Sheet
Avid Bioservices Inc
Apr-2014 | Apr-2015 | Apr-2016 | Apr-2017 | Apr-2018 | Apr-2019 | Apr-2020 | Apr-2021 | Apr-2022 | Apr-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
78
|
68
|
61
|
47
|
42
|
32
|
36
|
170
|
126
|
39
|
|
Cash Equivalents |
78
|
68
|
61
|
47
|
42
|
32
|
36
|
170
|
126
|
39
|
|
Total Receivables |
1
|
4
|
3
|
8
|
4
|
12
|
12
|
25
|
26
|
28
|
|
Accounts Receivables |
1
|
3
|
3
|
7
|
4
|
12
|
12
|
25
|
26
|
28
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
6
|
7
|
16
|
33
|
16
|
7
|
11
|
12
|
26
|
44
|
|
Other Current Assets |
1
|
1
|
1
|
2
|
6
|
1
|
1
|
1
|
2
|
2
|
|
Total Current Assets |
86
|
81
|
82
|
90
|
68
|
51
|
60
|
208
|
180
|
113
|
|
PP&E Net |
2
|
15
|
24
|
26
|
27
|
26
|
47
|
56
|
130
|
220
|
|
PP&E Gross |
2
|
15
|
24
|
26
|
27
|
26
|
47
|
56
|
130
|
220
|
|
Accumulated Depreciation |
7
|
8
|
10
|
12
|
12
|
15
|
18
|
21
|
25
|
30
|
|
Other Long-Term Assets |
2
|
2
|
3
|
2
|
2
|
2
|
1
|
2
|
120
|
119
|
|
Total Assets |
91
N/A
|
98
+8%
|
109
+12%
|
118
+8%
|
96
-19%
|
78
-18%
|
108
+37%
|
266
+147%
|
430
+62%
|
451
+5%
|
|
Liabilities | |||||||||||
Accounts Payable |
2
|
10
|
8
|
3
|
2
|
4
|
6
|
9
|
10
|
25
|
|
Accrued Liabilities |
8
|
9
|
13
|
5
|
3
|
4
|
4
|
10
|
11
|
10
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
Other Current Liabilities |
12
|
18
|
36
|
55
|
33
|
15
|
30
|
52
|
54
|
38
|
|
Total Current Liabilities |
22
|
37
|
58
|
63
|
38
|
23
|
45
|
71
|
76
|
74
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
97
|
142
|
142
|
|
Other Liabilities |
1
|
1
|
1
|
2
|
2
|
2
|
21
|
20
|
38
|
46
|
|
Total Liabilities |
23
N/A
|
38
+68%
|
59
+54%
|
65
+9%
|
40
-38%
|
25
-37%
|
66
+160%
|
188
+186%
|
255
+36%
|
262
+2%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
403
|
454
|
509
|
537
|
559
|
561
|
571
|
560
|
431
|
431
|
|
Additional Paid In Capital |
471
|
513
|
559
|
591
|
615
|
614
|
613
|
638
|
606
|
620
|
|
Total Equity |
68
N/A
|
59
-13%
|
50
-15%
|
54
+7%
|
56
+4%
|
53
-5%
|
42
-21%
|
78
+85%
|
175
+125%
|
190
+9%
|
|
Total Liabilities & Equity |
91
N/A
|
98
+8%
|
109
+12%
|
118
+8%
|
96
-19%
|
78
-18%
|
108
+37%
|
266
+147%
|
430
+62%
|
451
+5%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
26
|
28
|
34
|
44
|
56
|
56
|
57
|
61
|
62
|
63
|
|
Preferred Shares Outstanding |
1
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|